A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
F cells measure the presence of fetal hemoglobin, a heritable quantitative trait in adults that accounts for substantial phenotypic diversity of sickle cell disease and beta thalassemia. We applied a genome-wide association mapping strategy to individuals with contrasting extreme trait values and mapped a new F cell quantitative trait locus to BCL11A, which encodes a zinc-finger protein, on chromosome 2p15. The 2p15 BCL11A quantitative trait locus accounts for 15.1% of the trait variance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BCL11A is a repressor of HbF gene expression.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [14]
Citations
Cites
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Population Structure and Eigenanalysis
Patterson, N., Price, A. L., & Reich, D. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020190 · Cited by 5,280
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
A General Test of Association for Quantitative Traits in Nuclear Families
Abecasis, G. R., Cardon, L. R., & Cookson, W. O. C. (2000) · The American Journal of Human Genetics · doi:10.1086/302698 · Cited by 1,126
Disorders of hemoglobin genetics, pathophysiology, and clinical management
Steinberg, M. H. (2001) · Cited by 438
Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management
Somervaille, T. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401119 · Cited by 432
Bcl11a is essential for normal lymphoid development
Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351
Thein, S. L., Menzel, S., Peng, X., Best, S., Jiang, J., Close, J., Silver, N., Gerovasilli, A., Ping, C., Yamaguchi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611393104 · Cited by 314
Self-citationGenetic influences on F cells and other hematologic variables: a twin heritability study
Garner, C., Tatu, T., Reittie, J. E., Littlewood, T., Darley, J., Cervino, S., Farrall, M., Kelly, P., Spector, T. D., & Thein, S. L. (2000) · Blood · doi:10.1182/blood.v95.1.342 · Cited by 274
Self-citationRegulation of human fetal hemoglobin: new players, new complexities
Bank, A. (2006) · Blood · doi:10.1182/blood-2005-05-2113 · Cited by 209
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866
Therapeutic genome editing: prospects and challenges
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Manzoni, C., Kia, D. A., Vandrovcova, J., Hardy, J., Wood, N. W., Lewis, P. A., & Ferrari, R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbw114 · Cited by 804
Cao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722
Validating therapeutic targets through human genetics
Plenge, R. M., Scolnick, E. M., & Altshuler, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4051 · Cited by 712
Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
“Furthermore, a recently reported parallel study also shows that BCL11A variants influence HbF levels in nonanemic Caucasians from a European twin study (29).”
BackgroundAn Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Science · doi:10.1126/science.1242088 · Cited by 653
Lettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Fetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
Genetics of Human Cardiovascular Disease
Kathiresan, S., & Srivastava, D. (2012) · Cell · doi:10.1016/j.cell.2012.03.001 · Cited by 496
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2021838 · Cited by 477
Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch
Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478
Higgs, D. R., Engel, J. D., & Stamatoyannopoulos, G. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60283-3 · Cited by 434
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
Esrick, E. B., Lehmann, L. E., Biffi, A., Achebe, M., Brendel, C., Ciuculescu, M. F., Daley, H., MacKinnon, B., Morris, E., Federico, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029392 · Cited by 449
Erythropoiesis: Development and Differentiation
Dzierzak, E., & Philipsen, S. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011601 · Cited by 394
Hemoglobin research and the origins of molecular medicine
Schechter, A. N. (2008) · Blood · doi:10.1182/blood-2008-04-078188 · Cited by 381
Developmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379
Rapid and Pervasive Changes in Genome-wide Enhancer Usage during Mammalian Development
Nord, A. S., Blow, M. J., Attanasio, C., Akiyama, J. A., Holt, A., Hosseini, R., Phouanenavong, S., Plajzer-Frick, I., Shoukry, M., Afzal, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.033 · Cited by 375
Borg, J., Papadopoulos, P., Georgitsi, M., Gutiérrez, L., Grech, G., Fanis, P., Phylactides, M., Verkerk, A. J. M. H., van der Spek, P. J., Scerri, C. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.630 · Cited by 371
Genome-wide association studies: potential next steps on a genetic journey
McCarthy, M. I., & Hirschhorn, J. N. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn289 · Cited by 359
Xu, J., Sankaran, V. G., Ni, M., Menne, T. F., Puram, R. V., Kim, W., & Orkin, S. H. (2010) · Genes & Development · doi:10.1101/gad.1897310 · Cited by 361
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium
Ganesh, S. K., Zakai, N. A., van Rooij, F. J. A., Soranzo, N., Smith, A. V., Nalls, M. A., Chen, M.-H., Kottgen, A., Glazer, N. L., Dehghan, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.466 · Cited by 358
Self-citationFehrmann, R. S. N., Jansen, R. C., Veldink, J. H., Westra, H.-J., Arends, D., Bonder, M. J., Fu, J., Deelen, P., Groen, H. J. M., Smolonska, A., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002197 · Cited by 331
The switch from fetal to adult hemoglobin.
Sankaran, V. G., & Orkin, S. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011643 · Cited by 333
Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326
Genetic modifiers of sickle cell disease
Steinberg, M. H., & Sebastiani, P. (2012) · American Journal of Hematology · doi:10.1002/ajh.23232 · Cited by 315
Martyn, G. E., Wienert, B., Yang, L., Shah, M., Norton, L. J., Burdach, J., Kurita, R., Nakamura, Y., Pearson, R. C. M., Funnell, A. P. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0085-0 · Cited by 300
Galarneau, G., Palmer, C. D., Sankaran, V. G., Orkin, S. H., Hirschhorn, J. N., & Lettre, G. (2010) · Nature Genetics · doi:10.1038/ng.707 · Cited by 269
Control of fetal hemoglobin: new insights emerging from genomics and clinical implications
Thein, S. L., Menzel, S., Lathrop, M., & Garner, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp401 · Cited by 250
Self-citationTranscriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Wilber, A., Nienhuis, A. W., & Persons, D. A. (2011) · Blood · doi:10.1182/blood-2010-11-316893 · Cited by 215
Advances in the understanding of haemoglobin switching
Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08105.x · Cited by 214
Sickle cell disease and stroke
Verduzco, L. A., & Nathan, D. G. (2009) · Blood · doi:10.1182/blood-2009-05-220921 · Cited by 207
Molecular basis of β thalassemia and potential therapeutic targets
Thein, S. L. (2018) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2017.06.001 · Cited by 209
Self-citationErythropoiesis: Model systems, molecular regulators, and developmental programs
Tsiftsoglou, A. S., Vizirianakis, I. S., & Strouboulis, J. (2009) · IUBMB Life · doi:10.1002/iub.226 · Cited by 199
HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers
Stadhouders, R., Aktuna, S., Thongjuea, S., Aghajanirefah, A., Pourfarzad, F., van IJcken, W., Lenhard, B., Rooks, H., Best, S., Menzel, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71520 · Cited by 209
Self-citationBradner, J. E., Mak, R., Tanguturi, S. K., Mazitschek, R., Haggarty, S. J., Ross, K., Chang, C. Y., Bosco, J., West, N., Morse, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006774107 · Cited by 211
Optimal management of β thalassaemia intermedia
Taher, A. T., Musallam, K. M., Cappellini, M. D., & Weatherall, D. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08486.x · Cited by 207
Discovering the genetics underlying foetal haemoglobin production in adults
Thein, S. L., & Menzel, S. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07650.x · Cited by 201
Self-citationGenetic Etiologies for Phenotypic Diversity in Sickle Cell Anemia
Steinberg, M. H. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.10 · Cited by 203
Piel, F. B., Rees, D. C., DeBaun, M. R., Nnodu, O., Ranque, B., Thompson, A. A., Ware, R. E., Abboud, M. R., Abraham, A., Ambrose, E. E., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00096-0 · Cited by 177
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease
Hoban, M. D., Orkin, S. H., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2015-09-618587 · Cited by 194
Nuinoon, M., Makarasara, W., Mushiroda, T., Setianingsih, I., Wahidiyat, P. A., Sripichai, O., Kumasaka, N., Takahashi, A., Svasti, S., Munkongdee, T., et al. (2010) · Human Genetics · doi:10.1007/s00439-009-0770-2 · Cited by 186
Taylor, J. G., Nolan, V. G., Mendelsohn, L., Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002095 · Cited by 184
A Functional Element Necessary for Fetal Hemoglobin Silencing
Sankaran, V. G., Xu, J., Byron, R., Greisman, H. A., Fisher, C., Weatherall, D. J., Sabath, D. E., Groudine, M., Orkin, S. H., Premawardhena, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103070 · Cited by 184
Haemoglobinopathies in southeast Asia.
Fucharoen, S., & Winichagoon, P. (2011) · Europe PMC (PubMed Central) · Cited by 181
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders
Bauer, D. E., Kamran, S. C., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood-2012-06-292078 · Cited by 177
Sedgewick, A. E., Timofeev, N., Sebastiani, P., So, J. C. C., Ma, E. S. K., Chan, L. C., Fucharoen, G., Fucharoen, S., Barbosa, C. G., Vardarajan, B. N., et al. (2008) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.06.007 · Cited by 172
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
Shi, L., Cui, S., Engel, J. D., & Tanabe, O. (2013) · Nature Medicine · doi:10.1038/nm.3101 · Cited by 172
Differences in the clinical and genotypic presentation of sickle cell disease around the world
Saraf, S. L., Molokie, R. E., Nouraie, M., Sable, C. A., Luchtman-Jones, L., Ensing, G. J., Campbell, A. D., Rana, S. R., Niu, X. M., Machado, R. F., et al. (2014) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.11.003 · Cited by 158
Sickle Cell Anemia and Its Phenotypes
Williams, T., & Thein, S. L. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021320 · Cited by 200
Self-citationGiardine, B., Borg, J., Higgs, D. R., Peterson, K. R., Philipsen, S., Maglott, D., Singleton, B. K., Anstee, D. J., Basak, A. N., Clark, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.785 · Cited by 158
Self-citationA genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis
Bell, S., Rigas, A. S., Magnusson, M. K., Ferkingstad, E., Allara, E., Bjornsdottir, G., Ramond, A., Sørensen, E., Halldorsson, G. H., Paul, D. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01575-z · Cited by 160
Liu, D., Zhang, X., Yu, L., Cai, R., Ma, X., Zheng, C., Zhou, Y., Liu, Q., Wei, X., Lin, L., et al. (2014) · Blood · doi:10.1182/blood-2014-03-561779 · Cited by 159
Molecular Basis and Genetic Modifiers of Thalassemia
Mettananda, S., & Higgs, D. R. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.003 · Cited by 130
Chang, K.-H., Smith, S. E., Sullivan, T., Chen, K., Zhou, Q., West, J. A., Liu, M., Liu, Y., Vieira, B. F., Sun, C., et al. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.009 · Cited by 155
Geographical genomics of human leukocyte gene expression variation in southern Morocco
Idaghdour, Y., Czika, W., Shianna, K. V., Lee, S. H., Visscher, P. M., Martin, H. C., Miclaus, K., Jadallah, S. J., Goldstein, D. B., Wolfinger, R. D., et al. (2010) · Nature Genetics · doi:10.1038/ng.495 · Cited by 151
Progress and promise in understanding the genetic basis of common diseases
Price, A. L., Spencer, C. C. A., & Donnelly, P. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2015.1684 · Cited by 147
Solovieff, N., Milton, J. N., Hartley, S. W., Sherva, R., Sebastiani, P., Dworkis, D. A., Klings, E. S., Farrer, L. A., Garrett, M. E., Ashley‐Koch, A. E., et al. (2009) · Blood · doi:10.1182/blood-2009-08-239517 · Cited by 154
Bauer, D. E., & Orkin, S. H. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.08.001 · Cited by 143
Amelioration of Sardinian 0 thalassemia by genetic modifiers
Galanello, R., Sanna, S., Perseu, L., Sollaino, M. C., Satta, S., Lai, M. E., Barella, S., Uda, M., Usala, G., Abecasis, G. R., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217901 · Cited by 164
Lee, Y. T., de Vasconcellos, J. F., Yuan, J., Byrnes, C., Noh, S.-J., Meier, E. R., Kim, K. S., Rabel, A., Kaushal, M., Muljo, S. A., et al. (2013) · Blood · doi:10.1182/blood-2012-12-472308 · Cited by 142
Immunological Tolerance During Fetal Development
Mold, J. E., & McCune, J. M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394299-9.00003-5 · Cited by 146
Challenges and future directions for studying effects of host genetics on the gut microbiome
Sanna, S., Kurilshikov, A., van der Graaf, A., Fu, J., & Zhernakova, A. (2022) · Nature Genetics · doi:10.1038/s41588-021-00983-z · Cited by 150
Genetic modifiers of the β‐haemoglobinopathies
Thein, S. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07084.x · Cited by 141
Self-citationFetal hemoglobin in sickle cell anemia
Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136
Vasculopathy and pulmonary hypertension in sickle cell disease
Potoka, K. P., & Gladwin, M. T. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2014 · Cited by 144
Minireview: Genetic basis of heterogeneity and severity in sickle cell disease
Habara, A. H., & Steinberg, M. H. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216636726 · Cited by 152
MicroRNA-486-3p Regulates γ-Globin Expression in Human Erythroid Cells by Directly Modulating BCL11A
Lulli, V., Romania, P., Morsilli, O., Cianciulli, P., Gabbianelli, M., Testa, U., Giuliani, A., & Marziali, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060436 · Cited by 133
Beta-thalassemia: from genotype to phenotype
Danjou, F., Anni, F., & Galanello, R. (2011) · Haematologica · doi:10.3324/haematol.2011.055962 · Cited by 129
Gene therapy for sickle cell disease: An update
Demirci, S., Uchida, N., & Tisdale, J. F. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.04.003 · Cited by 165
Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype
Luc, S., Huang, J., McEldoon, J. L., Somuncular, E., Li, D., Rhodes, C., Mamoor, S., Hou, S., Xu, J., & Orkin, S. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.064 · Cited by 130
Rivella, S. (2015) · Haematologica · doi:10.3324/haematol.2014.114827 · Cited by 139
Critical roles of Bcl11b in T‐cell development and maintenance of T‐cell identity
Liu, P., Li, P., & Burke, S. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00953.x · Cited by 136
Emerging genetic therapy for sickle cell disease
Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119
Farrell, J. J., Sherva, R., Chen, Z.-Y., Luo, H., Chu, B. F., Ha, S., Li, C. K., Lee, A., Li, R. C. H., Li, C. K., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317081 · Cited by 128
Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies
Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115
Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies
Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
Sher, F., Hossain, M. A., Seruggia, D., Schoonenberg, V. A. C., Yao, Q., Cifani, P., Dassama, L. M. K., Cole, M. A., Ren, C., Vinjamur, D. S., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0453-4 · Cited by 120
Stress Erythropoiesis is a Key Inflammatory Response
Paulson, R. F., Ruan, B., Hao, S., & Chen, Y. (2020) · Cells · doi:10.3390/cells9030634 · Cited by 127
Stress erythropoiesis: definitions and models for its study
Paulson, R. F., Hariharan, S., & Little, J. A. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.07.011 · Cited by 128
Update on fetal hemoglobin gene regulation in hemoglobinopathies
Bauer, D. E., & Orkin, S. H. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283420fd0 · Cited by 119
Update in the genetics of thalassemia: What clinicians need to know
Shang, X., & Xu, X. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.10.012 · Cited by 119
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation
Basak, A., Munschauer, M., Lareau, C. A., Montbleau, K. E., Ulirsch, J. C., Hartigan, C. R., Schenone, M., Lian, J., Wang, Y., Huang, Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0568-7 · Cited by 105
Hirschhorn, J. N., & Gajdos, Z. K. Z. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.091708.162036 · Cited by 119
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
Lettre, G., & Bauer, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01341-0 · Cited by 104
Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania
Nkya, S. W., Singh, T., Rooks, H., Mgaya, J., Mariki, H., Soka, D., Mmbando, B. P., Msaki, E. B., Kolder, I. C. R. M., Thein, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111464 · Cited by 113
Self-citationCurrent and future alternative therapies for beta-thalassemia major
Dreuzy, E. D., Bhukhai, K., Leboulch, P., & Payen, E. (2016) · Biomedical Journal · doi:10.1016/j.bj.2015.10.001 · Cited by 114
Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia.
Musallam, K. M., Sankaran, V. G., Cappellini, M. D., Duca, L., Nathan, D. G., & Taher, A. T. (2012) · Blood · doi:10.1182/blood-2011-09-382408 · Cited by 103
Pule, G. D., Mowla, S., Novitzky, N., Wiysonge, C. S., & Wonkam, A. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.1078235 · Cited by 113
Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia
Makani, J., Menzel, S., Nkya, S. W., Cox, S. E., Drašar, E., Soka, D., Komba, A., Mgaya, J., Rooks, H., Vasavda, N., et al. (2010) · Blood · doi:10.1182/blood-2010-08-302703 · Cited by 112
Self-citationMi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells
Amaya, M., Desai, M., Gnanapragasam, M. N., Wang, S. Z., Zu Zhu, S., Williams, D. C., & Ginder, G. D. (2013) · Blood · doi:10.1182/blood-2012-11-466227 · Cited by 102
Targeted Therapeutic Strategies for Fetal Hemoglobin Induction
Sankaran, V. G. (2011) · Hematology · doi:10.1182/asheducation-2011.1.459 · Cited by 117
Molecular Diagnosis of Thalassemias and Hemoglobinopathies
Sabath, D. E. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx047 · Cited by 101
Chapin, J. C., & Giardina, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00040-8 · Cited by 108
Sickle Cell Disease in Children
Meier, E. R., & Miller, J. L. (2012) · Drugs · doi:10.2165/11632890-000000000-00000 · Cited by 101
Evolutionary history of sickle-cell mutation: implications for global genetic medicine
Esoh, K. K., & Wonkam, A. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab004 · Cited by 103
Hb E/beta-thalassaemia: a common & clinically diverse disorder.
(2011) · Europe PMC (PubMed Central) · Cited by 96
Metadata
- Authors
- Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., Best, S., Spector, T. D., Farrall, M., Lathrop, M., & Thein, S. L.
- Affiliations
- King's College London (GB)
- University of California, Irvine (US)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- St Thomas' Hospital (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Thein, Swee Lay
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-09-02
- Volume
- 39
- Issue
- 10
- Pages
- 1197-1199
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2036308544
- Cited by
- 529
- References
- 16
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 22 · 2023: 27 · 2022: 24 · 2021: 34 · 2020: 43 · 2019: 25 · 2018: 33 · 2017: 27 · 2016: 37 · 2015: 27 · 2014: 25 · 2013: 26 · 2012: 20
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- fetal hemoglobin, F cells, quantitative trait loci, BCL11A, zinc finger proteins, sickle cell disease, beta-thalassemia, genome-wide association study
- MeSH terms
- Anemia, Sickle Cell, Carrier Proteins, Chromosome Mapping, Chromosomes, Human, Pair 2, Fetal Hemoglobin, Humans, Nuclear Proteins, Phenotype, Repressor Proteins, Genetic Variation, Genome, Human, Zinc Fingers, beta-Thalassemia, Quantitative Trait Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.